SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-003801
Filing Date
2023-02-07
Accepted
2023-02-07 09:15:38
Documents
13
Period of Report
2023-02-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 105391
  Complete submission text file 0001493152-23-003801.txt   343040

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE aeha-20230203.xsd EX-101.SCH 4404
3 XBRL DEFINITION FILE aeha-20230203_def.xml EX-101.DEF 27307
4 XBRL LABEL FILE aeha-20230203_lab.xml EX-101.LAB 37849
5 XBRL PRESENTATION FILE aeha-20230203_pre.xml EX-101.PRE 25927
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7169
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Aesther Healthcare Acquisition Corp. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 23593001
SIC: 2834 Pharmaceutical Preparations